ABIRATERONE, 177Lu-PNT2002, GALLIUM (68GA) GOZETOTIDE , ENZALUTAMIDE
PBP-301
Phase 3 small_molecule active
Quick answer
ABIRATERONE, 177Lu-PNT2002, GALLIUM (68GA) GOZETOTIDE , ENZALUTAMIDE for Metastatic castration-resistant prostate cancer (mCRPC) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Metastatic castration-resistant prostate cancer (mCRPC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active